Drugs / MEDI7836
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02388347 | Mar 2015 → Jan 2016 | — | MedImmune LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MEDI7836 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02388347 ↗ |
| Route | Subcutaneous | “MEDI7836 Dose 1 SC injection on Day 1” NCT02388347 ↗ |